🧠 Neuro MD Poďme urobiť poriadok v protilátkach!

The article addresses several important neurological topics. According to an FDA statement, 14 cases of vitamin B6 deficiency were reported in Parkinson's disease patients taking levodopa/carbidopa at doses exceeding 1000 mg daily, with symptoms appearing between 23 and 132 months after treatment initiation. These seizures typically had a focal character with secondary generalization and responded poorly to antiepileptic drugs but very well to vitamin B6 supplementation. The FDA recommends monitoring B6 levels before treatment initiation and regularly during therapy. The article further explains the nomenclature and associations of various ganglioside antibodies with neurological disorders such as Guillain-Barré syndrome, Miller-Fisher syndrome, and other polyneuropathies. The sensitivity of anti-GQ1b testing in Miller-Fisher syndrome is greater than 90 percent with 100 percent specificity.